BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mazereeuw-Hautier J, Hoeger PH, Benlahrech S, Ammour A, Broue P, Vial J, Ohanessian G, Léauté-Labrèze C, Labenne M, Vabres P. Efficacy of propranolol in hepatic infantile hemangiomas with diffuse neonatal hemangiomatosis. J Pediatr. 2010;157:340-342. [PMID: 20488455 DOI: 10.1016/j.jpeds.2010.04.003] [Cited by in Crossref: 102] [Cited by in F6Publishing: 77] [Article Influence: 8.5] [Reference Citation Analysis]
Number Citing Articles
1 Maaloul I, Aloulou H, Hentati Y, Kamoun T, Mnif Z, Hachicha M. Infantile hepatic hemangioendothelioma successfully treated by low dose of propranolol. Presse Med 2017;46:454-6. [PMID: 28318668 DOI: 10.1016/j.lpm.2017.01.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
2 Fay A, Nguyen J, Waner M. Conceptual approach to the management of infantile hemangiomas. J Pediatr 2010;157:881-8.e1-5. [PMID: 20884010 DOI: 10.1016/j.jpeds.2010.08.013] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
3 Yuan W, Wang X. Propranolol Participates in the Treatment of Infantile Hemangioma by Inhibiting HUVECs Proliferation, Migration, Invasion, and Tube Formation. Biomed Res Int 2021;2021:6636891. [PMID: 33575332 DOI: 10.1155/2021/6636891] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Wagner MJ, Cranmer LD, Loggers ET, Pollack SM. Propranolol for the treatment of vascular sarcomas. J Exp Pharmacol 2018;10:51-8. [PMID: 30233257 DOI: 10.2147/JEP.S146211] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
5 Filippi L, Cavallaro G, Fiorini P, Malvagia S, Della Bona M, Giocaliere E, Bagnoli P, Dal Monte M, Mosca F, Donzelli G, la Marca G. Propranolol concentrations after oral administration in term and preterm neonates. The Journal of Maternal-Fetal & Neonatal Medicine 2013;26:833-40. [DOI: 10.3109/14767058.2012.755169] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
6 Jeng MR, Fuh B, Blatt J, Gupta A, Merrow AC, Hammill A, Adams D. Malignant transformation of infantile hemangioma to angiosarcoma: Response to chemotherapy with bevacizumab: Angiosarcoma: Response to Chemotherapy With Bevacizumab. Pediatr Blood Cancer 2014;61:2115-7. [DOI: 10.1002/pbc.25067] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 5.3] [Reference Citation Analysis]
7 Kuroda T, Hoshino K, Nosaka S, Shiota Y, Nakazawa A, Takimoto T. Critical hepatic hemangioma in infants: recent nationwide survey in Japan. Pediatr Int. 2014;56:304-308. [PMID: 24689756 DOI: 10.1111/ped.12347] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
8 Ernst L, Grabhorn E, Brinkert F, Reinshagen K, Königs I, Trah J. Infantile Hepatic Hemangioma: Avoiding Unnecessary Invasive Procedures. Pediatr Gastroenterol Hepatol Nutr 2020;23:72-8. [PMID: 31988877 DOI: 10.5223/pghn.2020.23.1.72] [Reference Citation Analysis]
9 Yang K, Peng S, Chen L, Chen S, Ji Y. Efficacy of propranolol treatment in infantile hepatic haemangioma. J Paediatr Child Health 2019;55:1194-200. [DOI: 10.1111/jpc.14375] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Frommelt P, Juern A, Siegel D, Holland K, Seefeldt M, Yu J, Uhing M, Wade K, Drolet B. Adverse Events in Young and Preterm Infants Receiving Topical Timolol for Infantile Hemangioma. Pediatr Dermatol 2016;33:405-14. [DOI: 10.1111/pde.12869] [Cited by in Crossref: 40] [Cited by in F6Publishing: 29] [Article Influence: 6.7] [Reference Citation Analysis]
11 Tiwari P, Mahajan V, Muhrerkar K, Sunil BJ, Ramakrishnan A, Ganesan T. Effectiveness of Sorafenib in Hepatic Hemangioma. J Glob Oncol 2018;4:1-4. [PMID: 30241175 DOI: 10.1200/JGO.2016.008573] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
12 López-gutiérrez J. Clinical and economic impact of surgery for treating infantile hemangiomas in the era of propranolol: overview of single-center experience from La Paz Hospital, Madrid. Eur J Pediatr 2019;178:1-6. [DOI: 10.1007/s00431-018-3290-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
13 Campbell V, Beckett R, Abid N, Hoey S. Resolution of Consumptive Hypothyroidism Secondary to Infantile Hepatic Hemangiomatosis with a Combination of Propranolol and Levothyroxine. J Clin Res Pediatr Endocrinol 2018;10:294-8. [PMID: 29537380 DOI: 10.4274/jcrpe.4865] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
14 Raabe EH, Keefer JR, Mitchell SE, Hong K, DiFazio M, Strouse JJ. Subtotal splenic embolization is a safe and effective treatment for isolated splenic vascular tumors associated with consumptive coagulopathy. J Pediatr Hematol Oncol 2011;33:383-6. [PMID: 21606851 DOI: 10.1097/MPH.0b013e3182172515] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
15 Wang Y, Zhang X, Yang Y, Zhang J, Yang Y, Lu Y. Efficacy and Safety of 2% Topical Propranolol Cream for the Treatment of Proliferating Infantile Strawberry Hemangiomas. Indian J Pediatr 2017;84:425-9. [DOI: 10.1007/s12098-017-2303-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
16 Su WT, Xue JX, Ke YH. Noteworthy effects of a long-pulse Alexandrite laser for treatment of high-risk infantile hemangioma: A case report and literature review. World J Clin Cases 2019; 7(14): 1876-1883 [PMID: 31417934 DOI: 10.12998/wjcc.v7.i14.1876] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
17 Schmalz MJ, Radhakrishnan K. Vascular anomalies associated with hepatic shunting. World J Gastroenterol 2020; 26(42): 6582-6598 [PMID: 33268948 DOI: 10.3748/wjg.v26.i42.6582] [Reference Citation Analysis]
18 Uzunaslan D, Saygin C, Gungor S, Hasiloglu Z, Ozdemir N, Celkan T. Novel use of propranolol for management of pain in children with vertebral hemangioma: report of two cases. Childs Nerv Syst 2013;29:855-60. [PMID: 23306960 DOI: 10.1007/s00381-012-2012-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
19 Püttgen KB. Diagnosis and management of infantile hemangiomas. Pediatr Clin North Am 2014;61:383-402. [PMID: 24636652 DOI: 10.1016/j.pcl.2013.11.010] [Cited by in Crossref: 44] [Cited by in F6Publishing: 28] [Article Influence: 5.5] [Reference Citation Analysis]
20 Dreyfus I, Maza A, Mazereeuw-hautier J. Quoi de neuf dans les hémangiomes infantiles ? Archives de Pédiatrie 2013;20:809-16. [DOI: 10.1016/j.arcped.2013.03.020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
21 Kuroda T, Kumagai M, Nosaka S, Nakazawa A, Takimoto T, Hoshino K. Critical infantile hepatic hemangioma: results of a nationwide survey by the Japanese Infantile Hepatic Hemangioma Study Group. Journal of Pediatric Surgery 2011;46:2239-43. [DOI: 10.1016/j.jpedsurg.2011.09.007] [Cited by in Crossref: 24] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
22 Imteyaz H, Karnsakul W, Levine MA, Burrows PE, Benson J, Hsu S, Schwarz KB. Unusual case of hypothyroidism in an infant with hepatic hemangioma. J Pediatr Gastroenterol Nutr 2012;54:692-5. [PMID: 21716131 DOI: 10.1097/MPG.0b013e31822a3221] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
23 Mhanna A, Franklin WH, Mancini AJ. Hepatic Infantile Hemangiomas Treated with Oral Propranolol-A Case Series: Hepatic Infantile Hemangiomas. Pediatric Dermatology 2011;28:39-45. [DOI: 10.1111/j.1525-1470.2010.01355.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 23] [Article Influence: 3.5] [Reference Citation Analysis]
24 Greenberger S, Bischoff J. Infantile hemangioma-mechanism(s) of drug action on a vascular tumor. Cold Spring Harb Perspect Med 2011;1:a006460. [PMID: 22229118 DOI: 10.1101/cshperspect.a006460] [Cited by in Crossref: 53] [Cited by in F6Publishing: 48] [Article Influence: 5.9] [Reference Citation Analysis]
25 Tian R, Liang Y, Wang J, Shan Y, Gao H, Zhang L, Xie C, Li J, Xu M, Gu S. Propranolol for infantile hepatic hemangioendothelioma: Clinical evaluation of drug efficacy and safety using a single-center patient cohort. Ann Hepatol 2020;19:530-4. [PMID: 32532590 DOI: 10.1016/j.aohep.2020.04.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Hogeling M. Propranolol for Infantile Hemangiomas: A Review. Curr Derm Rep 2012;1:179-85. [DOI: 10.1007/s13671-012-0026-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
27 Balma-mena A, Chakkittakandiyil A, Weinstein M, Lansang P, Ho N, Cammisuli S, Pope E. Propranolol in the Management of Infantile Hemangiomas: Clinical Response and Predictors. J Cutan Med Surg 2012;16:169-73. [DOI: 10.1177/120347541201600306] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
28 Shi H, Song H, Wang J, Xia L, Yang J, Shang Y, Zhou H. Ultrasound in Assessing the Efficacy of Propranolol Therapy for Infantile Hemangiomas. Ultrasound in Medicine & Biology 2014;40:2622-9. [DOI: 10.1016/j.ultrasmedbio.2014.06.021] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
29 Aggarwal N, Tekes A, Bosemani T. Infantile Hepatic Hemangioma: Role of Dynamic Contrast-Enhanced Magnetic Resonance Angiography. J Pediatr 2015;167:940-940.e1. [PMID: 26216655 DOI: 10.1016/j.jpeds.2015.06.068] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
30 Rubinstein JC, Christison-lagay ER. Successful treatment of visceral infantile hemangioma of the omentum and mesentery with propranolol. Journal of Pediatric Surgery Case Reports 2014;2:302-4. [DOI: 10.1016/j.epsc.2014.06.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
31 Drolet BA, Frommelt PC, Chamlin SL, Haggstrom A, Bauman NM, Chiu YE, Chun RH, Garzon MC, Holland KE, Liberman L. Initiation and use of propranolol for infantile hemangioma: report of a consensus conference. Pediatrics. 2013;131:128-140. [PMID: 23266923 DOI: 10.1542/peds.2012-1691] [Cited by in Crossref: 304] [Cited by in F6Publishing: 219] [Article Influence: 30.4] [Reference Citation Analysis]
32 Chen ZG, Zheng JW, Yuan ML, Zhang L, Yuan WE. A novel topical nano-propranolol for treatment of infantile hemangiomas. Nanomedicine: Nanotechnology, Biology and Medicine 2015;11:1109-15. [DOI: 10.1016/j.nano.2015.02.015] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
33 Madan N, Arnon R, Arnon R. Evaluation of cardiac manifestations in pediatric liver transplant candidates: Cardiac evaluation children pre-liver transplant. Pediatric Transplantation 2012;16:318-28. [DOI: 10.1111/j.1399-3046.2012.01667.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
34 Menapace D, Mitkov M, Towbin R, Hogeling M. The changing face of complicated infantile hemangioma treatment. Pediatr Radiol 2016;46:1494-506. [PMID: 27450406 DOI: 10.1007/s00247-016-3643-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
35 Nguyen HP, Pickrell BB, Wright TS. Beta-blockers as therapy for infantile hemangiomas. Semin Plast Surg 2014;28:87-90. [PMID: 25045334 DOI: 10.1055/s-0034-1376259] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
36 Avagyan S, Klein M, Kerkar N, Demattia A, Blei F, Lee S, Rosenberg HK, Arnon R. Propranolol as a first-line treatment for diffuse infantile hepatic hemangioendothelioma. J Pediatr Gastroenterol Nutr 2013;56:e17-20. [PMID: 22331019 DOI: 10.1097/MPG.0b013e31824e50b7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
37 Yeh I, Bruckner AL, Sanchez R, Jeng MR, Newell BD, Frieden IJ. Diffuse infantile hepatic hemangiomas: a report of four cases successfully managed with medical therapy. Pediatr Dermatol. 2011;28:267-275. [PMID: 21517953 DOI: 10.1111/j.1525-1470.2011.01421.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 27] [Article Influence: 3.5] [Reference Citation Analysis]
38 Liu X, Qu X, Zheng J, Zhang L. Effectiveness and Safety of Oral Propranolol versus Other Treatments for Infantile Hemangiomas: A Meta-Analysis. PLoS One 2015;10:e0138100. [PMID: 26375455 DOI: 10.1371/journal.pone.0138100] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
39 Maruani A, Piram M, Sirinelli D, Herbreteau D, Saliba E, Machet MC, Lorette G. Visceral and mucosal involvement in neonatal haemangiomatosis. J Eur Acad Dermatol Venereol 2012;26:1285-90. [PMID: 22044599 DOI: 10.1111/j.1468-3083.2011.04285.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
40 Wagner MJ, Ravi V, Menter DG, Sood AK. Endothelial cell malignancies: new insights from the laboratory and clinic. NPJ Precis Oncol 2017;1:11. [PMID: 29872699 DOI: 10.1038/s41698-017-0013-2] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
41 Shamir SB, Kurian J, Kogan-liberman D, Taragin BH. Hepatic Imaging in Neonates and Young Infants: State of the Art. Radiology 2017;285:763-77. [DOI: 10.1148/radiol.2017170305] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
42 Sciveres M, Marrone G, Pipitone S, Riva S, Spada M, Gridelli B, Maggiore G. Successful First-line Treatment With Propranolol of Multifocal Infantile Hepatic Hemangioma With High-flow Cardiac Overload. Journal of Pediatric Gastroenterology & Nutrition 2011;53:693-5. [DOI: 10.1097/mpg.0b013e3182201a4e] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
43 Gnarra M, Behr G, Kitajewski A, Wu JK, Anupindi SA, Shawber CJ, Zavras N, Schizas D, Salakos C, Economopoulos KP. History of the infantile hepatic hemangioma: From imaging to generating a differential diagnosis. World J Clin Pediatr 2016; 5(3): 273-280 [PMID: 27610342 DOI: 10.5409/wjcp.v5.i3.273] [Cited by in CrossRef: 32] [Cited by in F6Publishing: 22] [Article Influence: 5.3] [Reference Citation Analysis]
44 Menezes MD, McCarter R, Greene EA, Bauman NM. Status of propranolol for treatment of infantile hemangioma and description of a randomized clinical trial. Ann Otol Rhinol Laryngol 2011;120:686-95. [PMID: 22097156 DOI: 10.1177/000348941112001010] [Cited by in Crossref: 39] [Cited by in F6Publishing: 31] [Article Influence: 3.5] [Reference Citation Analysis]
45 Chim H, Armijo BS, Miller E, Gliniak C, Serret MA, Gosain AK. Propranolol induces regression of hemangioma cells through HIF-1α-mediated inhibition of VEGF-A. Ann Surg 2012;256:146-56. [PMID: 22580939 DOI: 10.1097/SLA.0b013e318254ce7a] [Cited by in Crossref: 93] [Cited by in F6Publishing: 35] [Article Influence: 9.3] [Reference Citation Analysis]
46 Thompson PA, Chintagumpala M. Renal and hepatic tumors in the neonatal period. Semin Fetal Neonatal Med. 2012;17:216-221. [PMID: 22595862 DOI: 10.1016/j.siny.2012.04.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
47 Khanna D, Chakravarty P, Arora P, Jain R, Mittal M. Large multifocal cutaneous hemangioma along lines of Blaschko with cardiac failure treated with propranolol. Pediatr Dermatol 2015;32:e18-22. [PMID: 25516210 DOI: 10.1111/pde.12476] [Reference Citation Analysis]
48 Tal R, Dotan M, Lorber A. Approach to haemangiomatosis causing congestive heart failure. Acta Paediatr 2016;105:600-4. [DOI: 10.1111/apa.13359] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
49 Pride HB, Tollefson M, Silverman R. What's new in pediatric dermatology? Journal of the American Academy of Dermatology 2013;68:899.e1-899.e11. [DOI: 10.1016/j.jaad.2013.03.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
50 Luu M, Frieden IJ. Haemangioma: clinical course, complications and management. Br J Dermatol 2013;169:20-30. [PMID: 23701395 DOI: 10.1111/bjd.12436] [Cited by in Crossref: 70] [Cited by in F6Publishing: 50] [Article Influence: 8.8] [Reference Citation Analysis]
51 Okuno T, Tokuriki S, Yoshino T, Tanaka N, Ohshima Y. Diffuse neonatal hemangiomatosis in a very low-birthweight infant treated with erythropoietin: DNH and erythropoietin treatment. Pediatr Int 2015;57:e34-6. [DOI: 10.1111/ped.12517] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
52 Kwon EK, Seefeldt M, Drolet BA. Infantile hemangiomas: an update. Am J Clin Dermatol 2013;14:111-23. [PMID: 23338947 DOI: 10.1007/s40257-013-0008-x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
53 Horii KA, Drolet BA, Frieden IJ, Baselga E, Chamlin SL, Haggstrom AN, Holland KE, Mancini AJ, Mccuaig CC, Metry DW, Morel KD, Newell BD, Nopper AJ, Powell J, Garzon MC; for the Hemangioma Investigator Group. Prospective Study of the Frequency of Hepatic Hemangiomas in Infants with Multiple Cutaneous Infantile Hemangiomas: Hepatic Hemangiomas in Infants with Multiple Hemangiomas. Pediatric Dermatology 2011;28:245-53. [DOI: 10.1111/j.1525-1470.2011.01420.x] [Cited by in Crossref: 69] [Cited by in F6Publishing: 46] [Article Influence: 6.3] [Reference Citation Analysis]
54 Hsi Dickie B, Fishman SJ, Azizkhan RG. Hepatic vascular tumors. Semin Pediatr Surg. 2014;23:168-172. [PMID: 25241093 DOI: 10.1053/j.sempedsurg.2014.06.018] [Cited by in Crossref: 31] [Cited by in F6Publishing: 17] [Article Influence: 3.9] [Reference Citation Analysis]
55 Hsu TC, Wang JD, Chen CH, Chang TK, Wang TM, Chou CM, Lin HK. Treatment with propranolol for infantile hemangioma in 13 Taiwanese newborns and young infants. Pediatr Neonatol 2012;53:125-32. [PMID: 22503260 DOI: 10.1016/j.pedneo.2012.01.010] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
56 Seidmann L, Anspach L, Roth W. The embryo-placental CD15-positive "vasculogenic zones" as a source of propranolol-sensitive pediatric vascular tumors. Placenta 2016;38:93-9. [PMID: 26907387 DOI: 10.1016/j.placenta.2015.12.013] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
57 Georgountzou A, Karavitakis E, Klimentopoulou A, Xaidara A, Kakourou T. Propranolol treatment for severe infantile hemangiomas: a single-centre 3-year experience. Acta Paediatr 2012;101:e469-74. [PMID: 22804809 DOI: 10.1111/j.1651-2227.2012.02783.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
58 Léauté-Labrèze C. [Propranolol in infantile hemangiomas]. Arch Pediatr 2015;22:452-5. [PMID: 25753275 DOI: 10.1016/j.arcped.2015.01.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
59 Zavras N, Dimopoulou A, Machairas N, Paspala A, Vaos G. Infantile hepatic hemangioma: current state of the art, controversies, and perspectives. Eur J Pediatr 2020;179:1-8. [DOI: 10.1007/s00431-019-03504-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
60 Rössler J, Schill T, Bähr A, Truckenmüller W, Noellke P, Niemeyer CM. Propranolol for proliferating infantile haemangioma is superior to corticosteroid therapy--a retrospective, single centre study. J Eur Acad Dermatol Venereol 2012;26:1173-5. [PMID: 22035186 DOI: 10.1111/j.1468-3083.2011.04314.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
61 Rialon KL, Murillo R, Fevurly RD, Kulungowski AM, Christison-Lagay ER, Zurakowski D, Kozakewich HP, Alomari AI, Fishman SJ. Risk factors for mortality in patients with multifocal and diffuse hepatic hemangiomas. J Pediatr Surg. 2015;50:837-841. [PMID: 25783331 DOI: 10.1016/j.jpedsurg.2014.09.056] [Cited by in Crossref: 27] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
62 Fuchs J, Warmann SW, Urla C, Schäfer JF, Schmidt A. Management of benign liver tumors. Semin Pediatr Surg 2020;29:150941. [PMID: 32861445 DOI: 10.1016/j.sempedsurg.2020.150941] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
63 Craiglow BG, Antaya RJ. Management of infantile hemangiomas : current and potential pharmacotherapeutic approaches. Paediatr Drugs 2013;15:133-8. [PMID: 23456550 DOI: 10.1007/s40272-013-0008-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
64 Gunturi N, Ramgopal S, Balagopal S, Scott JX. Propranolol therapy for infantile hemangioma. Indian Pediatr 2013;50:307-13. [PMID: 23680605 DOI: 10.1007/s13312-013-0098-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
65 Léauté-Labrèze C, Prey S, Ezzedine K. Infantile haemangioma: part II. Risks, complications and treatment. J Eur Acad Dermatol Venereol 2011;25:1254-60. [PMID: 21569113 DOI: 10.1111/j.1468-3083.2011.04105.x] [Cited by in Crossref: 51] [Cited by in F6Publishing: 37] [Article Influence: 4.6] [Reference Citation Analysis]
66 Bosemani T, Puttgen KB, Huisman TA, Tekes A. Multifocal infantile hepatic hemangiomas--imaging strategy and response to treatment after propranolol and steroids including review of the literature. Eur J Pediatr. 2012;171:1023-1028. [PMID: 22234480 DOI: 10.1007/s00431-011-1671-7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
67 Blei F, Guarini A. Current workup and therapy of infantile hemangiomas. Clinics in Dermatology 2014;32:459-70. [DOI: 10.1016/j.clindermatol.2014.02.001] [Cited by in Crossref: 21] [Cited by in F6Publishing: 8] [Article Influence: 2.6] [Reference Citation Analysis]
68 Warren D, Diaz L, Levy M. Diffuse Hepatic Hemangiomas Successfully Treated Using Sirolimus and High-Dose Propranolol. Pediatr Dermatol 2017;34:e286-7. [DOI: 10.1111/pde.13219] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
69 Ji Y, Chen S, Xiang B, Xu Z, Jiang X, Liu X, Wang Q, Lu G, Yang L. Clinical features and management of multifocal hepatic hemangiomas in children: a retrospective study. Sci Rep 2016;6:31744. [PMID: 27530723 DOI: 10.1038/srep31744] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
70 Mcguire A, Fernandez-pineda I, Fishman SJ, Dickie BH. Pediatric hepatic vascular tumors. Seminars in Pediatric Surgery 2020;29:150970. [DOI: 10.1016/j.sempedsurg.2020.150970] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
71 Lee KC, Bercovitch L. Update on infantile hemangiomas. Semin Perinatol. 2013;37:49-58. [PMID: 23419763 DOI: 10.1053/j.semperi.2012.11.003] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
72 Hadzic N, Finegold MJ. Liver neoplasia in children. Clin Liver Dis. 2011;15:443-462, vii-vix. [PMID: 21689623 DOI: 10.1016/j.cld.2011.03.011] [Cited by in Crossref: 42] [Cited by in F6Publishing: 30] [Article Influence: 3.8] [Reference Citation Analysis]
73 Lou Y, Peng WJ, Cao Y, Cao DS, Xie J, Li HH. The effectiveness of propranolol in treating infantile haemangiomas: a meta-analysis including 35 studies. Br J Clin Pharmacol. 2014;78:44-57. [PMID: 24033819 DOI: 10.1111/bcp.12235] [Cited by in Crossref: 56] [Cited by in F6Publishing: 41] [Article Influence: 8.0] [Reference Citation Analysis]
74 Panditray S, Acharya S, Prusty N, Dany SS. Management of Head and Neck Hemangiomas in Adults: Oral Propranolol Versus Oral Itraconazole in Conjugation with Injection Sodium Tetra Decyl Sulphate. Indian J Otolaryngol Head Neck Surg 2019;71:566-73. [PMID: 31742022 DOI: 10.1007/s12070-018-1410-8] [Reference Citation Analysis]
75 Blatt J, Morrell DS, Buck S, Zdanski C, Gold S, Stavas J, Powell C, Burkhart CN. β-Blockers for Infantile Hemangiomas: A Single-Institution Experience. Clin Pediatr (Phila) 2011;50:757-63. [DOI: 10.1177/0009922811405517] [Cited by in Crossref: 39] [Cited by in F6Publishing: 29] [Article Influence: 3.5] [Reference Citation Analysis]
76 Sánchez-carpintero I, Ruiz-rodriguez R, López-gutiérrez J. Propranolol en hemangiomas infantiles: eficacia clínica, riesgos y recomendaciones. Actas Dermo-Sifiliográficas 2011;102:766-79. [DOI: 10.1016/j.ad.2011.05.003] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 2.7] [Reference Citation Analysis]
77 Ferrandiz L, Toledo-Pastrana T, Moreno-Ramirez D, Bardallo-Cruzado L, Perez-Bertolez S, Luna-Lagares S, Rios-Martin JJ. Diffuse neonatal hemangiomatosis with partial response to propranolol. Int J Dermatol. 2014;53:e247-e250. [PMID: 23834677 DOI: 10.1111/ijd.12155] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
78 Boralevi F. [What's new in paediatric dermatology?]. Ann Dermatol Venereol 2010;137 Suppl 4:S145-57. [PMID: 21193118 DOI: 10.1016/S0151-9638(10)70041-7] [Reference Citation Analysis]
79 Ni N, Guo S, Langer P. Current concepts in the management of periocular infantile (capillary) hemangioma. Curr Opin Ophthalmol 2011;22:419-25. [PMID: 21730838 DOI: 10.1097/ICU.0b013e32834994b4] [Cited by in Crossref: 24] [Cited by in F6Publishing: 7] [Article Influence: 2.4] [Reference Citation Analysis]
80 Vercellino N, Romanini MV, Pelegrini M, Rimini A, Occella C, Dalmonte P. The use of propranolol for complicated infantile hemangiomas. Int J Dermatol 2013;52:1140-6. [PMID: 23829783 DOI: 10.1111/j.1365-4632.2012.05795.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
81 Huang L, Nakayama H, Klagsbrun M, Mulliken JB, Bischoff J. Glucose transporter 1-positive endothelial cells in infantile hemangioma exhibit features of facultative stem cells. Stem Cells 2015;33:133-45. [PMID: 25187207 DOI: 10.1002/stem.1841] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 5.1] [Reference Citation Analysis]